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June Supplement 201058S AbstractsConclusions: CFE can be performed in CLI with high
technical success and low morbidity and mortality. The
analysis indicates that there was no significant effect of
run-off score upon time to recurrence of symptoms. Limb
salvage can be achieved even if options to restore inline flow
are limited. Our results show that restoration of inline flow
in most patients with critical ischemia is not necessary.
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Do Objective Performance Goals (OPGs) for Critical
Limb Ischemia (CLI) Apply to Everyday Vascular Sur-
gery Practice?
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Objectives: Recent efforts to develop standardized
metrics for outcomes in lower extremity revascularization
for CLI have led the SVS to develop OPGs, based on
aggregate data from randomized trials. It remains unknown
if these OPGs can be achieved in everyday vascular surgery
practice.
Methods: In accordance with SVS OPG criteria, we
studied all patients undergoing lower extremity bypass
surgery (LEB) for CLI within the Vascular Study Group of
New England (VS GNE). Each of the individual OPGs was
calculated in the VS GNE dataset and compared to pub-
lished SVS OPGs.
Results: We studied 838 patients who underwent 1,
063 LEB procedures. The primary efficacy endpoint, free-
dom from perioperative (30 day) death or any major ad-
verse limb event at one year, was similar between VS GNE
(75%, 95% CI 71-78%) and SVS OPG (77%, 95% CI
74-80%) (p  0.47). There were no significant differences
between the SVS OPGs and VS GNE results in most safety
or efficacy outcomes (Table). High-risk clinical (age80
years and tissue loss), anatomic (infra-popliteal anatomy),
or conduit (lack of single segment saphenous vein) catego-
ries derived from the SVS OPG cohort provided similar
discrimination of risk in the VS GNE dataset.
Conclusions: Community and academic centers in
everyday practice can meet OPGs derived from centers of
excellence in randomized trials of LEB. Quality improve-
ment initiatives, as well as clinical trials, should incorporate
OPGs in their outcome measures.Safety and Efficacy OPGs: Comparison of SVS -OPG and
the VS GNE Cohorts
Safety Outcomes
at 30 Days
SVS OPG Cohort
(mean, 95% CI)
Objective
Performance
Goal (OPG)
VS GNE Cohort
(mean, 95% CI)
p value
(SVS -OPG
vs VS GNE)
Above-Ankle
Amputation
1.9% (1.1-3.1%) 3% 1.0% (0.8-2.0%) p  NS
Major Adverse Limb
Events
6.1% (4.6-7.9%) 8% 2.5% (1.2-3.4%) p  0.04
Major Adverse
Cardiovascular
Events
6.2% (4.7-8.1%) 8% 4.2% (3.3-5.4%) p  NS
Efficacy Outcomes
at 1 Year
SVS OPG Cohort
(mean, 95% CI)
Objective
Performance
Goal (OPG)
VS GNE Cohort
(mean, 95% CI)
p value
(SVS -OPG
vs VS GNE)
Freedom From
Major Adverse
Limb Events or
Death
76.9% (74.0-79.9) 71% 76.3% (72.7-79.4) p  NS
Limb Salvage 88.9% (86.7-91.1) 84% 90.9% (88.2-93.0) p  NS
Survival 85.7% (83.3-88.1) 80% 91.6% (88.0-93.5) p  NS
Amputation-Free
Survival
76.5% (73.7-79.5) 71% 83.5% (79.0-86.2) p  NS
Freedom From
Reintervention or
Amputation
61.3% (58.0-64.9) 55% 73.2% (69.5-76.4) p  0.04
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The Use of Distal Arterial Access for Difficult Femoro-
popliteal Subintimal Angioplasty
George H. Meier, Paul Jones, Joseph S. Giglia. University
of Cincinnati, Cincinnati, OH
Objectives: As more challenging patients are subjected
to endovascular treatment of femoropopliteal occlusions,
technical failure is inevitable. Nonetheless, in a subset of
patients with a patent distal trifurcation vessel, retrograde
arterial access from the foot may be possible. This review
was undertaken to define the technique and use of distal
arterial access in treatment of femoropopliteal occlusions.
Methods: The records of all femoropopliteal subinti-
mal angioplasties done between September, 2007 and De-
cember, 2009 were reviewed with specific attention to the
use of distal arterial access in conjunction with conventional
access. Arteries approached, segments treated, and techni-
cal success was reviewed. Patency was documented by
clinical exam and confirmed by noninvasive lab evaluation
with specific attention to the distal access artery used.
Results: Approximately 250 femoropopliteal occlu-
sions were treated by subintimal angioplasty during this
interval. Of these, 14 patients required both proximal and
distal arterial access to treat their occlusions. The dorsalis
pedis artery was used for distal access in nine of these
patients while the posterior tibial artery was used in the
remaining five. All distal access was performed as a second
procedure after an initial diagnostic arteriogram and failed
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cal failure was the popliteal artery in 12 patients and the
proximal trifurcation vessels in two. Technical success was
achieved in all 14 patients. There were no complications
from the distal arterial access in any of the patients, docu-
mented in all cases by noninvasive lab assessment.
Conclusions: In a selected population of patients with
femoropopliteal arterial occlusion, distal arterial access in the
dorsalis pedis or posterior tibial arterymay allow technical success
to be achieved. Using the distal artery for retrograde access may
be an important adjunct for treatment of complicated femoro-
popliteal occlusions.
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Infrainguinal Bypass vs Endovascular Interventions for
Primary Treatment of Claudication
Jeffrey J. Siracuse, Kristina A. Giles, Frank B. Pomposelli,
Allen D. Hamdan, David R. Campbell, Mark C. Wyers,
April E. Nedeau, Marc L. Schermerhorn. Beth Israel Dea-
coness Medical Center, Boston, MA
Objectives: There has been increased use of percuta-
neous transluminal angioplasty /- stent (PTA) for clau-
dication. We set forth to investigate long-term outcomes of
PTA compared to bypass (BPG) as primary intervention.
Methods:Aretrospective cohort single institution review
of claudication interventions by BPG from 2001-2009 and
PTA from 2005-2009 looked at patient demographics, med-
ications, TASC classification, runoff, complications, and co-
morbidities. Patency (70% stenosis), symptom recurrence,
mortality, and reinterventions were used to assess durability.
Results:Wereviewed113BPGand104PTAof femoral-
popliteal lesionswithout prior interventions.Mean agewas 63
vs 69 (p  0.01). Length of stay (LOS) was 3.9 vs 1.2 days
(p  0.01). BPG had less TASC A (17 vs 40%, p  0.01),
more TASCC (36 vs 11%, p 0.01) and TASCD (13 vs 3%,
p  0.01) lesions. There was no difference in 30-day periop-
erative (1.8 vs 0%, NS) or long-term mortality (91 vs 92% - 3
years, NS). Wound infection was higher with BPG (15.9 vs
0%, p  0.01). BPG had improved primary patency (73% vs
42% - 3 years, p 0.01), freedom from symptom recurrence
(70 and 36% at 3 years p  0.01), and symptoms at last
follow-up (9% vs 27% p  0.01). There was no difference in
freedom from reinterventions (77 vs 66% at 3 years, NS).
None proceeded to amputation. Multivariate analysis shows
that PTA and TASCDwere predictive of patency failure (HR
2.5, 95% CI 1.4-4.4, HR 3.7, 95% CI 3.5-9) and recurrence
of symptoms (HR3.0, 95%CI 1.8-5,HR3.1, 95%CI 1.4-7).
Statin use postoperatively was predictive of patency (HR 0.6
95% CI 0.35-0.97) and freedom from symptoms (HR 0.6
95% CI 0.36-0.93).
Conclusions: BPG for claudication showed increased
patency and symptom relief despite treatment of more
extensive disease, but was associated with increased LOSand wound infection. Statins improved patency and free-
dom from symptom recurrence overall.
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Long-term Outcome After Surgical Intervention for
Common Femoral Artery (CFA) Occlusive Disease
Mital Y. Desai, Kurinchi Gurusamy, Janice C. Tsui, Meryl
Davis, Fiona Myint, Alan Wilson, Daryll Baker, George
Hamilton. Vascular Surgery, Royal Free Hampstead NHS
Trust, London, United Kingdom
Objectives: To retrospectively analyse long-term out-
come of common femoral endarterectomy (CFE) at a sin-
gle tertiary referral centre.
Methods: A review of outcome following CFE was
performed. Freedom from reintervention in ipsilateral limb
and limb salvage were determined using Kaplan-Meier
life-table analysis. Factors associated with adverse outcome
were assessed by Cox Regression analysis.
Results: CFE was performed on 87 limbs in 81 patients
(mean age 71 11; male 69%). 45 (52%) were performed for
incapacitating claudication and 42 (48%) for critical limb
ischaemia. 25 (29%)were performedwith adjunctive inflowor
outflow procedures. CFE was combined with profundaplasty
in 74 (85%) and patch angioplasty in 85 (98%) patients.
Technical success ratewas 100%with 30-day clinical success of
96%. Mean postoperative increase in ABPI was 0.32 0.19.
There were 4 (5%) major and 8 (9%) minor complications
with 1 (1%) perioperative death. Mean follow-up was 23
months (range 1-144 months). Primary patency and assisted
patency at 3 years were 93% and 99% respectively. There was
no difference in patency in CFE performed alone or as com-
bined procedure. No patient-related or intraoperative factors
were associatedwith increased risk of recurrence of symptoms.
Freedom from reintervention in ipsilateral limb was 79% at 2
years and 62% at 6 years. Freedom from amputation at 6 years
was 87% and significantly increased amputation risk was iden-
tified in patients on haemodialysis for chronic renal failure (by
long-rank test, p 0.001).
Conclusions:CommonFemoral Endarterectomy is safe,
durable and effective and can be performed under local anaes-
thesia which is helpful for limb salvage in unfit patients. It is
gold standard for occlusive CFA disease against which emerg-
ing endovascular therapies should be compared.
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